Medicus Pharma To Participate in the 38th Annual Roth Conference

Weekly Voice editorial staff
0 Min Read

Company Exec. Chairman & CEO in a fireside chat is expected to highlight the role of Skinject in an autosomal dominant rare disease, AI-enabled drug development strategy and partnering readiness

- Advertisement -
Company Exec. Chairman & CEO in a fireside chat is expected to highlight the role of Skinject in an autosomal dominant rare disease, AI-enabled drug development strategy and partnering readiness
Share This Article